BIOGEN IDEC INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 10245
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9158
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
C07K PEPTIDES 5131
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 396
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
7604989 Inhibition of apoptosis process and improvement of cell performanceJul 10, 02Oct 20, 09[C12N]
7582299 Cripto-specific antibodiesSep 20, 04Sep 01, 09[A61K, C07K]
7531174 Cripto blocking antibodies and uses thereofOct 23, 03May 12, 09[A61K]
6955810 Method for the treatment of inflammatory disordersNov 30, 01Oct 18, 05[A61K, C07K]
6897297 Hydrophobically-modified protein compositions and methodsMay 26, 00May 24, 05[C07K]
6197311 Induction of cytotoxic T-lymphocyte responsesFeb 17, 98Mar 06, 01[A61K, C12Q]
6159730 Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising sameMar 30, 99Dec 12, 00[C12N]
5866125 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofApr 18, 96Feb 02, 99[A61K, C07H, C12N]
5840298 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofApr 18, 96Nov 24, 98[A61K, C07H, C12N]
5811524 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofJun 07, 95Sep 22, 98[A61K, C07H, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0183,882 COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODYAbandonedMar 11, 15Jul 02, 15[C07K]
2014/0134,164 TREATMENT OF MULTIPLE SCLEROSISAbandonedJan 17, 14May 15, 14[A61K]
2013/0330,332 TREATMENT OF PEMPHIGUSAbandonedAug 16, 13Dec 12, 13[A61K]
2013/0273,041 USE OF CHIMERIC ANTI-CD20 ANTIBODY AS IN VITRO OR IN VIVO PURGING AGENT IN PATIENTS RECEIVING BMT OR PBSC TRANSPLANTAbandonedJun 10, 13Oct 17, 13[A61K]
2013/0273,042 TREATMENT OF MULTIPLE SCLEROSISAbandonedJun 11, 13Oct 17, 13[A61K]
2013/0183,288 NON-FUCOSYLATED ANTIBODIESAbandonedMar 28, 08Jul 18, 13[A61K, C07K]
2013/0084,289 TREATMENT OF MULTIPLE SCLEROSISAbandonedNov 20, 12Apr 04, 13[A61K]
2010/0203,010 MODULATION OF TUMOR MICROENVIRONMENTAbandonedMar 28, 08Aug 12, 10[A61K, A61P]
2010/0189,716 TREATMENT OF HODGKINS LYMPHOMAAbandonedMar 28, 08Jul 29, 10[A61K, C12N, A61P]
2010/0130,515 Polymorphs and solvates of a pharmaceutical and method of makingAbandonedJul 13, 09May 27, 10[A61K, C07D, A61P]
2010/0003,252 BLOCKING IMMUNE RESPONSE TO A GRAFTAbandonedSep 08, 09Jan 07, 10[A61K]
2009/0226,430 RECOMBINANT ANTI-CD4 ANTIBODIES FOR HUMAN THERAPYAbandonedFeb 29, 08Sep 10, 09[A61K]
2009/0221,036 RECOMBINANT ANTI-CD4 ANTIBODIES FOR HUMAN THERAPYAbandonedJul 02, 08Sep 03, 09[C12P, C12N]
2009/0124,791 IDENTIFICATION OF UNIQUE BINDING INTERACTIONS BETWEEN CERTAIN ANTIBODIES AND THE HUMAN B7.1 AND B7.2 CO-STIMULATORY ANTIGENSAbandonedJul 11, 08May 14, 09[C07K]
2009/0104,594 Bioreactor Process Control System and MethodAbandonedDec 22, 05Apr 23, 09[C12Q, C12M]
2009/0061,511 GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICSAbandonedAug 17, 07Mar 05, 09[C12N]
2009/0047,668 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the sameAbandonedJun 25, 07Feb 19, 09[C12Q, C12N]
2009/0018,314 GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICSAbandonedAug 17, 07Jan 15, 09[C07K]
7452534 Recombinant anti-CD4 antibodies for human therapyExpiredJul 10, 00Nov 18, 08[A61K]
2008/0282,363 METHODS FOR PRODUCING HUMAN ANTIBODIES IN SCID MICEAbandonedMar 11, 08Nov 13, 08[A01K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.